{"name":"Neothetics, Inc","slug":"neothetics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LIPO-102","genericName":"LIPO-102","slug":"lipo-102","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"LIPO-102","genericName":"LIPO-102","slug":"lipo-102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPZDUzN3dNV1V4b2tTczBWVU9ZdGk5bklMNlhsbXM1RXRqVjZyYkRQUUZTS2QwcTUzLWhIU1V1RzJOTS1WbjcxbjVzVUFKYnVFOFhqdHdXdVZkODJyRFl2cHh4LVNEcHV0T2xmbk9LY3hCNWtkZkNXWFdJS2RhR3oteWg1c3pmMmJWREh0UjcwUWNMSTJPRENOZXppUTVMdExIekRPckF3?oc=5","date":"2017-06-26","type":"trial","source":"BioPharma Dive","summary":"Neothetics reduced to nothing after failed double chin trial - BioPharma Dive","headline":"Neothetics reduced to nothing after failed double chin trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQcVMtQ0MySjR3S3YydG1ZdGRkak1WQV9VY294VEJGT2djeUhiVDRNUDduNzBZTDRxMU5CeXowNWMtd0VOUVp3c253RC00Q25LYVVZNW1HaVFFZlpJT2c0X3RTcFhxVVk5OW1yWUd2bFRERUNPQ0xEaXcxb001Q0VIZzF2ZU0?oc=5","date":"2016-07-27","type":"pipeline","source":"SEC.gov","summary":"EDGAR Filing Documents for 0001564590-16-015343 - SEC.gov","headline":"EDGAR Filing Documents for 0001564590-16-015343","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}